Skip to main content

Webinar

How to maximize the ROI of RWD

Optum experts give a snapshot of commonly encountered pitfalls when using RWD and recommendations to help avoid them in this PSMA webinar.

Top pitfalls observed when using real-world data

The life sciences industry is increasingly drawing upon real-world data (RWD) to inform a host of business functions across the product life cycle. These include clinical trial support, market insight, comparative effectiveness, understanding care standards and more.

Despite the richness of insight available through EHR and claims-based data assets, we sometimes encounter concerns from end users about data quality and its ability to support the analytic goals of an organization. These concerns are often the result of misconceptions around what RWD reflects versus the desired analytic purpose.

During this PMSA webinar, our experts provide a useful snapshot of some commonly encountered pitfalls and recommendations to help avoid them.

Related healthcare insights

Article

How real-world evidence can inform pharma strategies in 2025

Health economics and outcomes research (HEOR) can play a key role in helping the life sciences industry improve patient outcomes.

Article

4 ways small biopharma can harness RWD

Small and emerging biopharma companies are already having an impact on the industry. Learn how RWD can enhance the ability to innovate.

Guide

Real-world data centralized teams

Expanding the use of RWD requires expertise and leadership. Learn how to maximize the success of a centralized RWD team.